Completed PHASE4 INTERVENTIONAL 3-arm NCT02816710

Conbercept Injection in Treatment of Severe Proliferative Diabetic Retinopathy

Different Conbercept Injection Methods in Treatment of Severe Proliferative Diabetic Retinopathy

Sponsor: Ruijin Hospital

Conditions Proliferative Diabetic Retinopathy Tractional Retinal Detachment

Interventions Conbercept

Updated 9 times since 2017 Last updated: Nov 2, 2019 Started: Jul 31, 2016 Primary completion: Sep 30, 2017 Completion: Sep 30, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Proliferative Diabetic Retinopathy and Tractional Retinal Detachment, this trial is completed. The trial is conducted by Ruijin Hospital and has accumulated 9 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2023 — Jul 2024 [monthly]

Completed PHASE4
Dec 2022 — Jan 2023 [monthly]

Completed PHASE4
Jan 2021 — Dec 2022 [monthly]

Completed PHASE4

▶ Show 4 earlier versions

Dec 2019 — Jan 2021 [monthly]

Completed PHASE4

Status: Unknown Status → Completed
Jul 2018 — Dec 2019 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
Feb 2017 — Jul 2018 [monthly]

Recruiting PHASE4
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE4

First recorded

Jul 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ruijin Hospital

Data source: Ruijin Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China